This brand name is authorized in Cyprus, Estonia, Croatia, Malta, Romania
The drug TEMELOR contains one active pharmaceutical ingredient (API):
1
Lorazepam
UNII O26FZP769L - LORAZEPAM
|
Lorazepam is a benzodiazepine with anxiolytic, sedative and hypnotic properties. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
TEMELOR Tablet | MPI, EU: SmPC | ||
TEMELOR Solution for injection | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
N05BA06 | Lorazepam | N Nervous system → N05 Psycholeptics → N05B Anxiolytics → N05BA Benzodiazepine derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EE | Ravimiamet | Identifier(s): 1769801, 1769812 |
Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-199858664, HR-H-641923492, HR-H-785933953, HR-H-956450782 |
Country: MT | Medicines Authority | Identifier(s): MA032/13401, MA032/14501, MA032/14502, MA032/14503 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W66829001, W66829002 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.